Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16096-31-4

Post Buying Request

16096-31-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16096-31-4 Usage

Uses

Its primary use is as a reactive diluent in epoxy resin systems to reduce viscosity and to allow higher filler loading.

Production Methods

The compound results from condensation of hexanediol with epichlorohydrin followed by dehydrochlorination with caustic.

Contact allergens

This chemical is a reactive diluent in epoxy resins.

Check Digit Verification of cas no

The CAS Registry Mumber 16096-31-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,9 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16096-31:
(7*1)+(6*6)+(5*0)+(4*9)+(3*6)+(2*3)+(1*1)=104
104 % 10 = 4
So 16096-31-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H10O3.C6H14O2/c1(5-3-8-5)7-2-6-4-9-6;7-5-3-1-2-4-6-8/h5-6H,1-4H2;7-8H,1-6H2

16096-31-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,6-Hexanediol Diglycidyl Ether

1.2 Other means of identification

Product number -
Other names 1,6-Hexanediol diglycidyl ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Adhesives and sealant chemicals
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16096-31-4 SDS

16096-31-4Synthetic route

1,6-hexanediol
629-11-8

1,6-hexanediol

epichlorohydrin
106-89-8

epichlorohydrin

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

Conditions
ConditionsYield
With tetrabutyl-ammonium chloride; sodium hydroxide In water at 40℃; for 2h;68.2%
With tetrabutylammomium bromide; sodium hydroxide In water at 40℃; for 2h;
Etherification;
tin(IV) chloride Etherification;
1,6-bis(allyloxy)hexane
81866-56-0

1,6-bis(allyloxy)hexane

A

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

B

C12H22O3
1246463-46-6

C12H22O3

Conditions
ConditionsYield
With dihydrogen peroxide; benzonitrile; triethylamine In water at 60℃; for 25h; Conversion of starting material;A 29%
B 44%
1,6-hexanediol
629-11-8

1,6-hexanediol

epichlorohydrin
106-89-8

epichlorohydrin

A

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

B

6-hydroxy hexyl glycidyl ether

6-hydroxy hexyl glycidyl ether

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran for 5h; Heating;A 14 g
B 50 g
1,6-hexanediol
629-11-8

1,6-hexanediol

1,2-Epoxy-3-bromopropane
3132-64-7

1,2-Epoxy-3-bromopropane

A

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

B

6-hydroxy hexyl glycidyl ether

6-hydroxy hexyl glycidyl ether

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran for 7h; Heating;A 35 g
B 35 g
1-chloro-3-[6-(3-chloro-2-hydroxy-propoxy)-hexyloxy]-propan-2-ol
20387-39-7

1-chloro-3-[6-(3-chloro-2-hydroxy-propoxy)-hexyloxy]-propan-2-ol

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

Conditions
ConditionsYield
With sodium hydride In hexane; toluene at 20℃; for 0.0833333h; Cyclization;228 mg
1,6-hexanediol
629-11-8

1,6-hexanediol

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: SnCl4 / toluene; heptane / 3 h / 90 °C
2: 228 mg / NaH / toluene; hexane / 0.08 h / 20 °C
View Scheme
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

2-oxo-1,3-dioxolane-4-carboxylic acid
871835-30-2

2-oxo-1,3-dioxolane-4-carboxylic acid

C20H30O14

C20H30O14

Conditions
ConditionsYield
With chromium(III) acetylacetonate; triethylamine In tetrahydrofuran at 80℃; for 16h;100%
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

(2-dimethylamino-1-(4-morpholinophenyl)-2-(4-carboxyphenylmethyl)butan-1-one)

(2-dimethylamino-1-(4-morpholinophenyl)-2-(4-carboxyphenylmethyl)butan-1-one)

C60H82N4O12

C60H82N4O12

Conditions
ConditionsYield
With tetrabutylammomium bromide In acetonitrile for 10h; Reflux;88%
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

3-{[6-(2,3-dihydroxypropoxy)hexyl]oxy}-1,2-propanediol

3-{[6-(2,3-dihydroxypropoxy)hexyl]oxy}-1,2-propanediol

Conditions
ConditionsYield
With water; trifluoroacetic acid Hydrolysis; ring cleavage;63%
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

n-Octylamine
111-86-4

n-Octylamine

di[(2-hydroxy-3-octylamino)propyloxy]hexamethylene
189192-11-8

di[(2-hydroxy-3-octylamino)propyloxy]hexamethylene

Conditions
ConditionsYield
In ethanol for 4h;105 g
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

acetic acid 2-acetoxy-1-[6-(2,3-diacetoxy-propoxy)-hexyloxymethyl]-ethyl ester

acetic acid 2-acetoxy-1-[6-(2,3-diacetoxy-propoxy)-hexyloxymethyl]-ethyl ester

Conditions
ConditionsYield
Acetoxylation; acetylation; ring cleavage;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

reduced [3H]glutathione
148102-19-6

reduced [3H]glutathione

A

oxidized glutathione

oxidized glutathione

B

(S)-2-Amino-4-[2-[3-(6-{3-[2-((S)-4-amino-4-carboxy-butyrylamino)-2-(carboxymethyl-carbamoyl)-ethylsulfanyl]-2-hydroxy-propoxy}-hexyloxy)-2-hydroxy-propylsulfanyl]-1-(carboxymethyl-carbamoyl)-ethylcarbamoyl]-butyric acid

(S)-2-Amino-4-[2-[3-(6-{3-[2-((S)-4-amino-4-carboxy-butyrylamino)-2-(carboxymethyl-carbamoyl)-ethylsulfanyl]-2-hydroxy-propoxy}-hexyloxy)-2-hydroxy-propylsulfanyl]-1-(carboxymethyl-carbamoyl)-ethylcarbamoyl]-butyric acid

Conditions
ConditionsYield
In phosphate buffer; dimethyl sulfoxide at 20℃; for 18h; pH=7.4; Enzyme kinetics; Kinetics; Further Variations:; Reaction partners; Condensation;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

2-methyl-2-morpholin-4-yl-1-(4-piperazinylphenyl)propan-1-one
886463-09-8

2-methyl-2-morpholin-4-yl-1-(4-piperazinylphenyl)propan-1-one

C48H76N6O8

C48H76N6O8

Conditions
ConditionsYield
1,8-diazabicyclo[5.4.0]undec-7-ene In toluene for 10h; Heating / reflux;
2-Benzoylbenzoic acid
85-52-9

2-Benzoylbenzoic acid

1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

C40H42O10

C40H42O10

Conditions
ConditionsYield
With triphenylphosphine at 110℃; for 8h;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

malonic acid dimethyl ester
108-59-8

malonic acid dimethyl ester

1,6-bis[(γ-butyrolactone-4-yl)methyloxy]hexane

1,6-bis[(γ-butyrolactone-4-yl)methyloxy]hexane

Conditions
ConditionsYield
Stage #1: 1,6-diglycidyloxy hexamethylene; malonic acid dimethyl ester With potassium tert-butylate In tert-butyl alcohol for 16h; Reflux;
Stage #2: With sodium hydroxide In tert-butyl alcohol at 70℃; for 5h;
64 g
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

1,6-hexanediol
629-11-8

1,6-hexanediol

Octamethyltrisiloxane
107-51-7

Octamethyltrisiloxane

acrylic acid
79-10-7

acrylic acid

C84H178O36Si6

C84H178O36Si6

Conditions
ConditionsYield
Stage #1: octamethyltrisiloxabe; acrylic acid With dihydrogen hexachloroplatinate at 80℃; for 48h;
Stage #2: 1,6-diglycidyloxy hexamethylene With tetrabutylammomium bromide; hydroquinone at 100℃; for 14h;
Stage #3: 1,6-hexanediol With sulfuric acid at 140℃; for 6h;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

2,2-bis(hydroxymethyl)propionic acid
4767-03-7

2,2-bis(hydroxymethyl)propionic acid

C22H42O12

C22H42O12

Conditions
ConditionsYield
With triphenylphosphine at 140℃; for 3h;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

carbon dioxide
124-38-9

carbon dioxide

C14H22O8

C14H22O8

Conditions
ConditionsYield
With [N,N'-bis(2-pyridinylmethyl)cyclohexane-1,2-diamine]iron(II) chloride; tetrabutylammomium bromide In neat (no solvent) at 100℃; under 22502.3 Torr; for 4h; Catalytic behavior; Time; Autoclave; Glovebox; Green chemistry;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

C12H18N2

C12H18N2

C37H64N2O8

C37H64N2O8

Conditions
ConditionsYield
at 75℃; for 3h;
1,6 hexanediol diglycidyl ether
16096-31-4

1,6 hexanediol diglycidyl ether

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

C18H28N3O4(1+)

C18H28N3O4(1+)

Conditions
ConditionsYield
Stage #1: 1,6-diglycidyloxy hexamethylene; 1,2-diamino-benzene at 65℃; for 1.5h; Inert atmosphere;
Stage #2: With sulfuric acid; sodium nitrite In water at -10℃; for 3.5h;

16096-31-4Downstream Products

16096-31-4Relevant articles and documents

Diol glycidyl ether-bridged cyclens: Preparation and their applications in gene delivery

Yi, Wen-Jing,Feng, Zhi-Hua,Zhang, Qin-Fang,Zhang, Ji,Li, Ling-Dong,Zhu, Wen,Yu, Xiao-Qi

, p. 2413 - 2421 (2011)

Polymeric 1,4,7,10-tetraazacyclododecanes (cyclens) using diol glycidyl ether with different chain length as bridges (5a-e) were designed and synthesized from various diols, 1,7-diprotected cyclen and epichlorohydrin. The molecular weights of the title polymers were measured by GPC with good polydispersity. Agarose gel retardation and fluorescent titration using ethidium bromide showed good DNA-binding ability of 5. They could retard plasmid DNA (pDNA) at an N/P ratio of 4-6 and form polyplexes with sizes around 100-250 nm from an N/P ratio of 10 to 60 and relatively low zeta-potential values (5-22 mV). The cytotoxicity of 5 assayed by MTT is much lower than that of 20 kDa PEI. In vitro transfection against A549 and 293 cells showed that the transfection efficiency (TE) of 5c/DNA polyplexes is close to that of 20 kDa PEI at an N/P ratio of 5. Structure-activity relationship (SAR) of 5 was discussed in their DNA-binding, cytotoxicity, and transfection studies. The TE of 5c/DNA polyplexes could be improved by the introduction of 50 μM of chloroquine, the endosomolytic agents, to pretreated cells. These studies may extend the application areas of macrocyclic polyamines, especially for cyclen.

PROCESS FOR PRODUCING EPOXY COMPOUND

-

Page/Page column 6-7, (2012/02/06)

According to the present, invention, a process for producing an epoxy compound, where an epoxy compound can be selectively produced from olefins with good yield at low cost in a safe manner by a simple operation under mild conditions without using a quaternary ammonium salt or a metal compound, is provided. The present invention relates to a process for producing an epoxy compound, comprising epoxidizing a carbon-carbon double bond of an organic compound having a carbon-carbon double bond by using hydrogen peroxide as an oxidant, wherein the epoxidation is carried by out using an organic nitrile compound and an organic amine compound.

Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro

Boogaard,De Kloe,Bierau,Kuiken,Borkulo,VanSittert

, p. 485 - 502 (2007/10/03)

1. Some glycidyl ethers (GE) have been shown to be direct mutagens in short-term in vitro tests and consequently GE are considered to be potentially mutagenic in vivo. However, GE may be metabolically inactivated in the body by two different enzymatic routes: conjugation of the epoxide moiety with the endogenous tripeptide glutathione (GSH) catalysed by glutathione S-transferase (GST) or hydrolysis of the epoxide moiety catalysed by epoxide hydrolase (EH). 2. The metabolic inactivation of five different GE, the diglycidyl ethers of bisphenol A (BADGE), 4,4'-dihydroxy-3,3',5,5'-tetramethylbiphenyl (Epikote YX4000) and 1,6-hexanediol (HDDGE) and the GE of 1-dodecanol (C12GE) and o-cresol (o-CGE), has been studied in subcellular fractions of human, C3H mouse and F344 rat liver and lung. 3. All GE were chemically very stable and resistant to aqueous hydrolysis, but were rapidly hydrolysed by EH in cytosolic and microsomal fractions of liver and lung. The aromatic GE were very good substrates for EH. In general, microsomal EH is more efficient than cytosolic EH in hydrolysis of GE, and human microsomes are more efficient than rodent microsomes. 4. The more water-soluble GE, o-CGE and HDDGE, were good substrates for GST whereas the more lipophilic GE, YX4000 and C12GE, were poor substrates for GST. In general, rodents are more efficient in GSH conjugation of GE than humans. 5. In general, the epoxide groups of YX4000 are the most and those of HDDGE the least efficiently inactivated of the five GE under study. For the other three GE no general trend was observed: the relative efficiency of inactivation varied with organ and species. 6. The large variation in metabolism observed with five representative GE indicate that GE have variable individual properties and should not be considered as a single, homogenous class of compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16096-31-4